An expanding portfolio of next generation sequencing (NGS) panels and library preparation products for the accurate detection of genetic variants.
A broad range of array products for cytogenetics, rare disease, cancer and reproductive health research.
9 April 2018
OGT announces organisational changes
On 1st April 2018 Dr John Anson took over as CEO from Dr Mike Evans, who has become a non-executive director of OGT’s board.
7 March 2018
OGT enhances customer experience with new Cytocell website
OGT has launched a new version of its Cytocell® fluorescence in situ hybridisation (FISH) probes website.